Furthermore, the mixed and partly mild behavioural phenotypes in our cell-type-selective Gria1-ablation models align not only with such treatment studies but also with genetic studies [18, 78, 79], suggesting that many different molecular alterations can contribute to schizophrenia by causing synaptic dysfunction in the hippocampus. The gene discussed is GRIA1; the disease is schizophrenia.